Detection of alcohol consumption during pregnancy-Current and future biomarkers

Neuroscience and Biobehavioral Reviews

Volumn 31, Issue 2, 2007, Pages 261-269

  Littner, Yoav ^a   Bearer, Cynthia F ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alcohol; Biological markers; Birth defects; Fetal alcohol effects; Pregnancy

Indexed keywords

5 HYDROXYTRYPTOPHOL; ACETALDEHYDE; ALCOHOL; BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; CYTOCHROME P450 2E1; DOLICHOL; ETHYL GLUCURONIDE; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; GLUCURONIDE; SIALIC ACID; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; DRINKING BEHAVIOR; HUMAN; MEAN CORPUSCULAR VOLUME; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEOMICS; PUBLIC HEALTH PROBLEM; RESEARCH; REVIEW; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; ETHANOL; FEMALE; HUMANS; PREGNANCY;

EID: 33846045535     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2006.06.025     Document Type: Review

References (85)

1. Allen J.P., et al. Carbohydrate-deficient transferrin, gamma-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women. Alcoholism: Clinical and Experimental Research 24 (2000) 492-496
2. Anni H., and Israel Y. Proteomics in alcohol research. Alcohol Research & Health 26 (2002) 219-232
3. Anttila P., et al. Method-dependent characteristics of carbohydrate-deficient transferrin measurements in the follow-up of alcoholics. Alcohol and Alcoholism 39 (2004) 59-63
4. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clinical Chemistry 47 (2001) 13-27
5. Baldi E., et al. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. Italian Journal of Gastroenterology 25 (1993) 429-432
6. Bean P., et al. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence. Alcoholism-Clinical and Experimental Research 25 (2001) 309-316
7. Bearer C., et al. A comparison of FAEE in meconium to maternal self reported drinking in predicting neurodevelopment. Pediatric Research 49 (2001) 183A
8. Bearer C.F., et al. Fatty acid ethyl esters in peripheral blood. Pediatric Research 31 (1992) 68A
9. Bearer C.F., et al. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol: Clinical and Experimental Research 23 (1999) 487-493
10. Bearer C.F., et al. Validation of a new biomarker of fetal exposure to alcohol. Journal of Pediatrics 143 (2003) 463-469
11. Bearer C.F., et al. Fatty Acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. Journal of Pediatrics 146 (2005) 824-830
12. Beck O., and Helander A. 5-hydroxytryptophol as a marker for recent alcohol intake. Addiction 98 (2003) 63-72
13. Bisaga A., et al. Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumption. Alcohol and Alcoholism 40 (2005) 214-218
14. Brinkmann B., et al. ROC analysis of alcoholism markers-100% specificity. International Journal of Legal Medicine 113 (2000) 293-299
15. Butcher G., et al. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification. Journal of Hepatology 19 (1993) 105-109
16. Caprara D., et al. A Guinea pig model for the identification of in utero alcohol exposure using fatty acid ethyl esters in neonatal hair. Pediatric Research 58 (2005) 1158-1163
17. CDC. Alcohol use among women of childbearing age-United States, 1991-1999. Morbidity & Mortality Weekly Report 51 (2002) 273-276
18. Chan D., et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Therapeutic Drug Monitoring 25 (2003) 271-278
19. Chan D., et al. Placental handling of fatty acid ethyl esters: perfusion and subcellular studies. Journal of Pharmacology and Experimental Therapeutics 310 (2004) 75-82
20. Chang G. Alcohol-screening instruments for pregnant women. Alcohol Research & Health 25 (2001) 204-209
21. Conigrave K.M., et al. Traditional markers of excessive alcohol use. Addiction 98 (2003) 31-43
22. Crook M., et al. Elevated serum sialic acid in pregnancy. Journal of Clinical Pathology 50 (1997) 494-495
23. Cudd T.A. Animal model systems for the study of alcohol teratology. Experimental Biology and Medicine 230 (2005) 389-393
24. Day N.L., et al. Prenatal exposure to alcohol: effect on infant growth and morphologic characteristics. Pediatrics 84 (1989) 536-541
25. Eckardt M.J., et al. Effects of moderate alcohol consumption on the central nervous system. Alcoholism-Clinical and Experimental Research 22 (1998) 998-1040
26. Goodlett C.R.H.K.H. Mechanisms of alcohol-induced damage to the developing nervous system. The Journal of The National Institute On Alcohol Abuse and Alcoholism 25 (2001) 175-184
27. Gorski N., et al. Reduced fatty acid ethyl ester synthase activity in the white blood cells of alcoholics. Alcoholism-Clinical and Experimental Research 20 (1996) 268-274
28. Grant T., et al. A pilot community intervention for young women with fetal alcohol spectrum disorders. Community Mental Health Journal 40 (2004) 499-511
29. Halmesmaki E., et al. Gamma-glutamyltransferase, aspartate and alanine aminotransferases and their ratio, mean cell volume and urinary dolichol in pregnant alcohol abusers. British Journal of Obstetrics and Gynaecology 99 (1992) 287-291
30. Halvorson M., et al. Comparative evaluation of the clinical utility of three markers of ethanol intake: the effect of gender. Alcoholism-Clinical and Experimental Research 17 (1993) 225-229
31. Harasymiw J., and Bean P. The combined use of the early detection of alcohol consumption (EDAC) test and carbohydrate-deficient transferrin to identify heavy drinking behaviour in males. Alcohol and Alcoholism 36 (2001) 349-353
32. Harasymiw J.W., et al. The early detection of alcohol consumption (EDAC) score in the identification of Heavy and at-risk drinkers from routine blood tests. Journal of Addictive Diseases 19 (2000) 43-59
33. Hartz A.J., et al. Identification of heavy drinkers using a combination of laboratory tests. Journal of Clinical Epidemiology 50 (1997) 1357-1368
34. Hawkins M.R., et al. Hematological concomitants of alcoholism: development and validation of a clinical screening technique. Journal of Substance Abuse Treatment 1 (1984) 271-276
35. Hazelett S.E., et al. Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: effects of gender and hemoglobin concentrations. Alcoholism: Clinical and Experimental Research 22 (1998) 1813-1819
36. Hillers V.N., et al. Determination of habitual alcohol intake from a panel of blood chemistries. Alcohol and Alcoholism 21 (1986) 199-205
37. Hultberg B., and Isaksson A. A possible explanation for the occurrence of increased beta-hexosaminidase activity in pregnancy serum. Clinica Chimica Acta 113 (1981) 135-140
38. Idiz N., et al. Serum sialic acid and gamma-glutamyltransferase levels in alcohol-dependent individuals. Forensic Science International 146 (2004) 67-70
39. Jacobson S.W., et al. Effects of alcohol exposure on infant reaction time. Alcoholism: Clinical and Experimental Research 18 (1994) 1125-1132
40. Javors M.A., and Johnson B.A. Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption. Addiction 98 (2003) 45-50
41. Johnson R., et al. Accurate assignment of ethanol origin in postmortem urine: liquid chromatographic-mass spectrometric determination of serotonin metabolites. Journal of Chromatography B 805 (2004) 223-234
42. Karkkainen P., et al. Serum beta-hexosaminidase as a marker of heavy drinking. Alcoholism-Clinical and Experimental Research 14 (1990) 187-190
43. Klein J., et al. Fatty acid ethyl esters: a novel biologic marker for heavy in utero ethanol exposure: a case report. Therapeutic Drug Monitoring 21 (1999) 644-646
44. Lichtenstein M.J., et al. Derivation and validation of a prediction rule for identifying heavy consumers of alcohol. Alcoholism-Clinical and Experimental Research 13 (1989) 626-630
45. Little B.B., et al. Failure to recognize fetal alcohol syndrome in newborn infants. American Journal of Diseases in Childhood 144 (1990) 1142-1146
46. Lucas D., et al. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcoholism-Clinical and Experimental Research 19 (1995) 362-366
47. Mac E., et al. A marker of fetal exposure to alcohol by meconium analysis. Pediatric Research 35 (1994) 238A
48. Neuhold L.A., et al. High-throughput proteomics for alcohol research. Alcoholism Clinical and Experimental Research 28 (2004) 203-210
49. Neumann T., and Spies C. Use of biomarkers for alcohol use disorders in clinical practice. Addiction 98 (2003) 81-91
50. Niemela O., et al. Hemoglobin-acetaldehyde adducts are elevated in women carrying alcohol-damaged fetuses. Alcoholism: Clinical and Experimental Research 15 (1991) 1007-1010
51. Nomura F., et al. Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry. Proteomics 4 (2004) 1187-1194
52. Pfutzer R., et al. Pancreatic cholesterol esterase, ES-10, and fatty acid ethyl ester synthase III gene expression are increased in the pancreas and liver but not in the brain or heart with long-term ethanol feeding in rats. Pancreas 25 (2002) 101-106
53. Pragst F., et al. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Science International 121 (2001) 76-88
54. Raucy J., et al. Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P4502E1. Alcoholism-Clinical and Experimental Research 19 (1995) 1369-1375
55. Raucy J., et al. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metabolism and Disposition 25 (1997) 1429-1435
56. Reynaud M., et al. Usefulness of carbohydrate-deficient transferrin in alcoholic patients with normal gamma-glutamyltranspeptidase. Alcoholism-Clinical and Experimental Research 2 (1998) 615-618
57. Robinson M.K., et al. Two-dimensional protein electrophoresis and multiple hypothesis testing to detect potential serum protein biomarkers in children with fetal alcohol syndrome. Electrophoresis 16 (1995) 1176-1183
58. Roine R. Effects of moderate drinking and alcohol abstinence on urinary dolichol levels. Alcohol 5 (1988) 229-231
59. Roine R., et al. Significant increases in urinary dolichol levels in bacterial infections, malignancies and pregnancy but not in other clinical conditions. Annals of Medicine 21 (1989) 13-16
60. Roine R., et al. Effect of alcohol on urinary and blood dolichols. Biochemistry and Cell Biology 70 (1992) 404-407
61. Romppanen J., et al. Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking. Alcoholism-Clinical and Experimental Research 26 (2002) 1234-1238
62. Russell M., and Skinner J.B. Early measures of materal alcohol misuse as predictors of adverse pregnancy outcomes. Alcoholism-Clinical and Experimental Research 12 (1998) 824-830
63. Russell M., et al. Screening for pregnancy risk-drinking. Alcoholism: Clinical and Experimental Research 18 (1994) 1156-1161
64. Russell M., et al. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. American Journal of Public Health 86 (1996) 1435-1439
65. Sampson P.D., et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology 56 (1997) 317-326
66. Sarkola T., et al. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse. Acta Obstetricia et Gynecologica Scandinavica 79 (2000) 359-366
67. Savage C.L., et al. Measurement of maternal alcohol consumption in a pregnant population. Substance Abuse 23 (2002) 211-214
68. Schloegl H., et al. Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples. International Journal of Legal Medicine 30 (2005) 1-6
69. Sillanaukee P., et al. Acetaldehyde-modified hemoglobin as a marker of alcohol consumption: comparison of two new methods. Journal of Laboratory and Clinical Medicine 120 (1992) 42-47
70. Sillanaukee P., et al. Sialic acid: new potential marker of alcohol abuse. Alcoholism: Clinical and Experimental Research 23 (1999) 1039-1043
71. Sillanaukee P., et al. Effect of hormone balance on carbohydrate-deficient transferrin and gamma-glutamyltrasferase in female social drinkers. Alcoholism-Clinical and Experimental Research 24 (2000) 1505-1509
72. Soderberg B.L., et al. Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples. Clinical Chemistry 45 (1999) 2183-2190
73. Stetter F., et al. Urinary dolichol-a doubtful marker of alcoholism. Alcoholism-Clinical and Experimental Research 15 (1991) 938-941
74. Stoler J.M., and Holmes L.B. Recognition of facial features of fetal alcohol syndrome in the newborn. American Journal of Medical Genetics 127C (2004) 21-27
75. Stoler J.M., et al. The prenatal detection of significant alcohol exposure with maternal blood markers. Journal of Pediatrics 133 (1998) 346-352
76. Stowell L., et al. Comparison of serum beta-hexosaminidase isoenzyme B activity with serum carbohydrate-deficient transferrin and other markers of alcohol abuse. Alcohol and Alcoholism 32 (1997) 703-714
77. Stratton K., et al. Fetal alcohol syndrome: diagnosis, epidemiology, prevention, and treatment. I.o. Medicine vol. 57 (1996), National Academy Press, Washington, DC
78. Streissguth A.P., et al. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcoholism: Clinical and Experimental Research 14 (1990) 662-669
79. Streissguth A.P., et al. Understanding the occurrence of secondary disabilities in clients with fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE). Final report (1996), University of Washington School of Medicine, Department of Psychiatry and Behavioral Sciences, Seattle, Washington
80. Takacs P., et al. Increased circulating lipid peroxides in severe preeclampsia activate NF-{kappa}B and upregulate ICAM-1 in vascular endothelial cells. FASEB Journal 15 (2001) 279-281
81. Uotila J., et al. Pregnancy-induced hypertension is associated with changes in maternal and umbilical blood antioxidants. Gynecologic and Obstetric Investigation 36 (1993) 153-157
82. Whitty J., et al. Cord blood carbohydrate-deficient transferrin levels are markedly higher than maternal. Journal of Maternal-Fetal Medicine 6 (1997) 45-48
83. Wisniewski K.E., et al. Increased urinary dolichol in newborns whose mothers were heavy alcohol users. Annals of Neurology 14 (1983) 382
84. Wurst F.M., et al. Ethyl glucuronide-a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol and Alcoholism 34 (1999) 71-77
85. Wurst F.M., et al. Concentration of fatty acid ethyl esters in hair of alcoholics: Comparison to other biological state markers and self reported-ethanol intake. Alcohol and Alcoholism 39 (2004) 33-38